FE Healthcare

💧 Bridging the Hydration Gap for Non-Diarrheal Illnesses in India Kenvue India has presented a crucial report highlighting the hydration gap in non-diarrheal illnesses, shedding light on an often-overlooked health challenge. With proper hydration playing a key role in recovery, this report underscores the need for greater awareness and action. 👉 Learn more about this important health issue and the steps we can take to improve hydration for better health outcomes: Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #HydrationAwareness #HealthInnovation #KenvueIndia #Healthcare #Wellness

💊 A Major Milestone for Alembic Pharma 🏆 Alembic Pharmaceuticals Limited Pharmaceuticals has received approval from the USFDA for its anti-epileptic drug, marking a significant step forward in healthcare innovation. This approval highlights India's growing presence in global pharma and its contributions to life-saving treatments. 🌍🩺 Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #PharmaInnovation #USFDAApproval #HealthcareLeadership

📢 Fortis Hospitals Mumbai Takes a Step Forward in Emergency Care 🏥 In a critical initiative to enhance accessibility and response during emergencies, Fortis Healthcare Mumbai has launched a dedicated helpline number. This effort addresses the growing need for reliable emergency contacts, ensuring timely assistance when it’s needed most. 🚑📞 Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #EmergencyCare #HealthcareInnovation #FortisHospitals

🌟 Year in Review: Major Medical Breakthroughs of 2024 🩺💡 As 2024 comes to a close, it’s time to reflect on the groundbreaking advancements in the world of healthcare. From cutting-edge technologies to innovative treatments, this year has witnessed remarkable strides that could shape the future of medicine. This article highlights the most impactful medical breakthroughs of the year—innovations that not only improved patient care but also pushed the boundaries of science and technology. 👉 Dive into the full list: Major Medical Breakthroughs of 2024 Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #MedicalInnovation #Healthcare #YearInReview #Breakthroughs2024 #FutureOfMedicine

🌍 Lupin Secures USFDA Approval for Generic HIV Treatment 💊 A remarkable achievement for Lupin as it receives USFDA approval for its generic version of Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate tablets, used in the treatment of HIV-1 infection. This approval highlights Lupin’s commitment to delivering affordable and high-quality treatments to address global health challenges. With the rising need for accessible HIV care, this is a vital step toward improving patient outcomes worldwide. Kudos to the Lupin team for their dedication to making a difference in healthcare! 👏 Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #USFDAApproval #HIVCare #GlobalHealth #Pharmaceuticals

🎉 Granules India Receives USFDA Approval for ADHD Treatment 🏥 A significant milestone for Granules India Limited as it secures USFDA approval for its generic version of Amphetamine Mixed Salts, a treatment for Attention Deficit Hyperactivity Disorder (ADHD). This marks another step forward in making critical medications more accessible and affordable for patients globally. Such approvals not only boost the pharmaceutical sector but also underline India's growing contribution to global healthcare solutions. Kudos to Granules India for their commitment to improving patient lives! Sushmita Panda Sakshi Kuchroo Roshun Povaiah Sumana Sarkar Syed Fazal Bari #PharmaInnovation #Healthcare #USFDAApproval #ADHDTreatment

🌍 Severe Asthma Cases Expected to Reach 1.89 Million by 2033 🌬️ A recent analysis highlights a concerning rise in severe asthma diagnoses, projecting 1.89 million cases in India by 2033. This underscores the urgent need for enhanced awareness, robust healthcare infrastructure, and innovative treatment options to address this growing burden. As healthcare professionals, policymakers, and innovators, we have a pivotal role in advancing solutions that improve patient outcomes and alleviate the challenges of managing chronic respiratory diseases. Let’s work together to combat this pressing issue and foster a healthier future! Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari GlobalData Plc GlobalData Healthcare #HealthcareInsights #AsthmaAwareness #PublicHealth #RespiratoryCare

🌟 Revolutionizing Asthma Care in India with AI 🌟 Cipla has launched an AI-powered mobile application designed to enhance early asthma detection and screening in India. This innovative solution is a significant step forward in leveraging technology to tackle one of the country's most pressing healthcare challenges. The app’s ability to assist in quick and accurate asthma diagnosis could improve patient outcomes, reduce healthcare costs, and raise awareness about respiratory health. It’s inspiring to see how AI continues to transform the healthcare landscape, making critical diagnostics accessible to more people. Kudos to Cipla for this forward-thinking initiative! 👏 Sushmita Panda Sakshi Kuchroo Sumana Sarkar Roshun Povaiah Syed Fazal Bari #HealthcareInnovation #AIinHealthcare #AsthmaCare #DigitalHealth

New WHO report reveals decline in per capita government health spending across all income groups- Subscribe to FE Healthcare Newsletter for more stories. #FE #FEHealthcare #Healthcare #FEHealthcareNewsletter #HealthcareNewsletter #LinkedInNewsletter #HealthIndustry #HealthcareSector #WHO #HealthAwareness #HealthcareInnovation #PublicHealth

#poll What is the biggest obstacle you encounter when trying to maintain a healthy lifestyle? Share your views. #FEHealthcare #Healthcare #HealthManagement #WellnessFirst #HealthPriority #HealthyLiving #WellnessJourney #SelfCare #HealthyLifestyle #HealthFocus #PrioritizeHealth #StayHealthy #Polloftheday